Kabra Drugs Shareholding

Kabra Drugs Ltd Shareholding Pattern

The Kabra Drugs Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Kabra Drugs Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Kabra Drugs Ltd (NSE: , BSE: 524322) operates in the Health technology sector and Pharmaceuticals: generic industry. Monitoring the Kabra Drugs Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Kabra Drugs Ltd Shareholding Pattern (Latest)

The latest Kabra Drugs Ltd shareholding for Mar 2026 is:

• Promoters: 0%
• FII: 0%
• DII: 0%
• Public: 100%
• Government: 0%

Promoter holding in Kabra Drugs Ltd remains stable, reflecting consistent long-term commitment.

Kabra Drugs Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Kabra Drugs Ltd.

• Mar 2026: 0%
• Dec 2025: 0%
• Sept 2025: 0%
• Jun 2025: 0%
• Mar 2025: 0%

Promoter stake remains largely stable, showing consistent ownership structure.

Kabra Drugs Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Kabra Drugs Ltd.

• Mar 2026: 0%
• Dec 2025: 0%
• Sept 2025: 0%
• Jun 2025: 0%
• Mar 2025: 0%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Kabra Drugs Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Mar 2026: 0%
• Dec 2025: 0%
• Sept 2025: 0%
• Jun 2025: 0%
• Mar 2025: 0%

DII holdings remain stable, reflecting steady institutional participation.

Kabra Drugs Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Mar 2026: 100%
• Dec 2025: 100%
• Sept 2025: 100%
• Jun 2025: 100%
• Mar 2025: 100%

Public holding remains stable with consistent retail participation.

Kabra Drugs Ltd Government Holding

Government holding in Kabra Drugs Ltd currently stands at 0%.

Kabra Drugs Ltd operates without significant government ownership.

Kabra Drugs Ltd Shareholding Analysis Summary

The Kabra Drugs Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Investors should monitor changes in Kabra Drugs Ltd shareholding for signals on institutional sentiment and ownership trends.

Regular monitoring of the Kabra Drugs Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.